FEATURED COMPANIES
- B. Braun Melsungen AG
- Smith & Nephew Plc
- Stryker Corp.
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Global Femoral Stems Market: About this market
The femoral stems market analysis considers sales from both cementless femoral stems and cemented femoral stems. Our analysis also considers the sales of femoral stems in Asia, Europe, North America, and ROW. In 2018, the cementless femoral stems segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as bone regeneration and their ability to adapt to different bone structures will play a significant role in the cementless femoral stems segment to maintain its market position. Also, our global femoral stems market report looks at factors such as the increasing prevalence of OA, osteoporosis, and RA, increasing number of hip replacement surgeries, and advances in the femoral stem. However, high cost of hip replacement surgeries and declining reimbursements, shortage of skilled orthopedic surgeons, and limitations of femoral stems may hamper the growth of the femoral stems industry over the forecast period.
Global Femoral Stems Market: Overview
Advances in femoral stems
Femoral stems have undergone significant improvements in terms of material and design. The use of tapered titanium stems has outplaced coated cobalt-chromium stems. Tapered titanium stems offer ease of insertion, less-stress shielding, less blood loss, less thigh pain, leading to short hospital stays. Thus, manufacturers have increased R&D efforts to introduce femoral stems with advanced designs and materials, making them more durable, long-lasting, and dependable. This will lead to the expansion of the global femoral stems market at a CAGR of nearly 4% during the forecast period.
The increasing demand for short stems among young patients
As many young and active patients are undergoing hip replacement, there is an increasing demand for implants that are durable, highly functional, and amenable for future successful revision. Short stems can be easily inserted through minimally inserted surgeries (MIS) and require less bone removal. They reduce or eliminate anterior thigh pain, facilitate physiological proximal bone loading providing better pain relief, radiographic stability, and improved functions. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global femoral stems market is moderately concentrated. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading femoral stems manufacturers, that include B. Braun Melsungen AG, Johnson & Johnson Services Inc., Smith & Nephew Plc, Stryker Corp., Zimmer Biomet Holdings Inc.
Also, the femoral stems market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The femoral stems market analysis considers sales from both cementless femoral stems and cemented femoral stems. Our analysis also considers the sales of femoral stems in Asia, Europe, North America, and ROW. In 2018, the cementless femoral stems segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as bone regeneration and their ability to adapt to different bone structures will play a significant role in the cementless femoral stems segment to maintain its market position. Also, our global femoral stems market report looks at factors such as the increasing prevalence of OA, osteoporosis, and RA, increasing number of hip replacement surgeries, and advances in the femoral stem. However, high cost of hip replacement surgeries and declining reimbursements, shortage of skilled orthopedic surgeons, and limitations of femoral stems may hamper the growth of the femoral stems industry over the forecast period.
Global Femoral Stems Market: Overview
Advances in femoral stems
Femoral stems have undergone significant improvements in terms of material and design. The use of tapered titanium stems has outplaced coated cobalt-chromium stems. Tapered titanium stems offer ease of insertion, less-stress shielding, less blood loss, less thigh pain, leading to short hospital stays. Thus, manufacturers have increased R&D efforts to introduce femoral stems with advanced designs and materials, making them more durable, long-lasting, and dependable. This will lead to the expansion of the global femoral stems market at a CAGR of nearly 4% during the forecast period.
The increasing demand for short stems among young patients
As many young and active patients are undergoing hip replacement, there is an increasing demand for implants that are durable, highly functional, and amenable for future successful revision. Short stems can be easily inserted through minimally inserted surgeries (MIS) and require less bone removal. They reduce or eliminate anterior thigh pain, facilitate physiological proximal bone loading providing better pain relief, radiographic stability, and improved functions. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global femoral stems market is moderately concentrated. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading femoral stems manufacturers, that include B. Braun Melsungen AG, Johnson & Johnson Services Inc., Smith & Nephew Plc, Stryker Corp., Zimmer Biomet Holdings Inc.
Also, the femoral stems market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- B. Braun Melsungen AG
- Smith & Nephew Plc
- Stryker Corp.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 08: GEOGRAPHIC LANDSCAPE
PART 10: DRIVERS AND CHALLENGES
Exhibit 01: Product overview
Exhibit 02: Global medical devices market
Exhibit 03: Segments of global medical devices market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Fixture - Market share 2018-2023 (%)
Exhibit 19: Comparison by fixture
Exhibit 20: Cementless femoral stems - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Cementless femoral stems - Year-over-year growth 2019-2023 (%)
Exhibit 22: Cemented femoral stems - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Cemented femoral stems - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by fixture
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 32: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 34: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Hip replacement surgeries per million population between 2010 and 2016
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: B. Braun Melsungen AG - Vendor overview
Exhibit 46: B. Braun Melsungen AG - Business segments
Exhibit 47: B. Braun Melsungen AG - Organizational developments
Exhibit 48: B. Braun Melsungen AG - Geographic focus
Exhibit 49: B. Braun Melsungen AG - Segment focus
Exhibit 50: B. Braun Melsungen AG - Key offerings
Exhibit 51: Johnson & Johnson Services, Inc. - Vendor overview
Exhibit 52: Johnson & Johnson Services, Inc. - Business segments
Exhibit 53: Johnson & Johnson Services, Inc. - Organizational developments
Exhibit 54: Johnson & Johnson Services, Inc. - Geographic focus
Exhibit 55: Johnson & Johnson Services, Inc. - Segment focus
Exhibit 56: Johnson & Johnson Services, Inc. - Key offerings
Exhibit 57: Smith & Nephew Plc - Vendor overview
Exhibit 58: Smith & Nephew Plc - Product segments
Exhibit 59: Smith & Nephew Plc - Organizational developments
Exhibit 60: Smith & Nephew Plc - Geographic focus
Exhibit 61: Smith & Nephew Plc - Segment focus
Exhibit 62: Smith & Nephew Plc - Key offerings
Exhibit 63: Stryker Corp. - Vendor overview
Exhibit 64: Stryker Corp. - Business segments
Exhibit 65: Stryker Corp. - Organizational developments
Exhibit 66: Stryker Corp. - Geographic focus
Exhibit 67: Stryker Corp. - Segment focus
Exhibit 68: Stryker Corp. - Key offerings
Exhibit 69: Zimmer Biomet Holdings Inc. - Vendor overview
Exhibit 70: Zimmer Biomet Holdings Inc. - Product segments
Exhibit 71: Zimmer Biomet Holdings Inc. - Organizational developments
Exhibit 72: Zimmer Biomet Holdings Inc. - Geographic focus
Exhibit 73: Zimmer Biomet Holdings Inc. - Segment focus
Exhibit 74: Zimmer Biomet Holdings Inc. - Key offerings
Exhibit 75: Validation techniques employed for market sizing
Exhibit 76: Definition of market positioning of vendors
PART 02: SCOPE OF THE REPORT
- Preface
- Currency conversion rates for US$
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segmentation by fixture
- Comparison by fixture
- Cementless femoral stems - Market size and forecast 2018-2023
- Cemented femoral stems - Market size and forecast 2018-2023
- Market opportunity by fixture
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
- Increasing focus on robotic hip replacement surgeries
- Increasing demand for short stems among young patients
- Increasing number of femoral stem replacement procedures
- Overview
- Landscape disruption
- Vendors covered
- Vendor classification
- Market positioning of vendors
- B. Braun Melsungen AG
- Johnson & Johnson Services Inc.
- Smith & Nephew Plc
- Stryker Corp.
- Zimmer Biomet Holdings Inc.
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
Exhibit 01: Product overview
Exhibit 02: Global medical devices market
Exhibit 03: Segments of global medical devices market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Fixture - Market share 2018-2023 (%)
Exhibit 19: Comparison by fixture
Exhibit 20: Cementless femoral stems - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Cementless femoral stems - Year-over-year growth 2019-2023 (%)
Exhibit 22: Cemented femoral stems - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Cemented femoral stems - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by fixture
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 32: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 34: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Hip replacement surgeries per million population between 2010 and 2016
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: B. Braun Melsungen AG - Vendor overview
Exhibit 46: B. Braun Melsungen AG - Business segments
Exhibit 47: B. Braun Melsungen AG - Organizational developments
Exhibit 48: B. Braun Melsungen AG - Geographic focus
Exhibit 49: B. Braun Melsungen AG - Segment focus
Exhibit 50: B. Braun Melsungen AG - Key offerings
Exhibit 51: Johnson & Johnson Services, Inc. - Vendor overview
Exhibit 52: Johnson & Johnson Services, Inc. - Business segments
Exhibit 53: Johnson & Johnson Services, Inc. - Organizational developments
Exhibit 54: Johnson & Johnson Services, Inc. - Geographic focus
Exhibit 55: Johnson & Johnson Services, Inc. - Segment focus
Exhibit 56: Johnson & Johnson Services, Inc. - Key offerings
Exhibit 57: Smith & Nephew Plc - Vendor overview
Exhibit 58: Smith & Nephew Plc - Product segments
Exhibit 59: Smith & Nephew Plc - Organizational developments
Exhibit 60: Smith & Nephew Plc - Geographic focus
Exhibit 61: Smith & Nephew Plc - Segment focus
Exhibit 62: Smith & Nephew Plc - Key offerings
Exhibit 63: Stryker Corp. - Vendor overview
Exhibit 64: Stryker Corp. - Business segments
Exhibit 65: Stryker Corp. - Organizational developments
Exhibit 66: Stryker Corp. - Geographic focus
Exhibit 67: Stryker Corp. - Segment focus
Exhibit 68: Stryker Corp. - Key offerings
Exhibit 69: Zimmer Biomet Holdings Inc. - Vendor overview
Exhibit 70: Zimmer Biomet Holdings Inc. - Product segments
Exhibit 71: Zimmer Biomet Holdings Inc. - Organizational developments
Exhibit 72: Zimmer Biomet Holdings Inc. - Geographic focus
Exhibit 73: Zimmer Biomet Holdings Inc. - Segment focus
Exhibit 74: Zimmer Biomet Holdings Inc. - Key offerings
Exhibit 75: Validation techniques employed for market sizing
Exhibit 76: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- B. Braun Melsungen AG
- Smith & Nephew Plc
- Stryker Corp.
The following companies are recognised as the key players in the global femoral stems market: B. Braun Melsungen AG, Johnson & Johnson Services Inc., Smith & Nephew Plc, Stryker Corp., Zimmer Biomet Holdings Inc.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing demand for short-stems among young patients.”
According to the report, one of the major drivers for this market is the advances in femoral stems.
Further, the report states that one of the major factors hindering the growth of this market is the high cost of hip replacement surgeries and declining reimbursements.
The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing demand for short-stems among young patients.”
According to the report, one of the major drivers for this market is the advances in femoral stems.
Further, the report states that one of the major factors hindering the growth of this market is the high cost of hip replacement surgeries and declining reimbursements.
The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
- B. Braun Melsungen AG
- Johnson & Johnson Services Inc.
- Smith & Nephew Plc
- Stryker Corp.
- Zimmer Biomet Holdings Inc.
Note: Product cover images may vary from those shown
LOADING...
